Developmental DisabilitiesNCT02132273
Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study
A study testing Educational Story in people with Developmental Disabilities and Sleep Disorders, run by Jennifer Accardo at 1 site in United States.
Trial summary
The investigators hypothesize that use of an educational story with pictures illustrating overnight sleep study procedure (also called polysomnography or PSG)accompanied by simple narrative will be a cost-effective, readily accepted intervention that will contribute to successful completion of sleep studies among… Read more about this study
- Who is it for?
- Ages 4 to 17 years
- Conditions the study is for
- Developmental Disabilities, Sleep Disorders, Polysomnography
- What is being tested?
- Educational Story
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 26 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2014to Jun 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 4 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Clinical recommendation for polysomnography to be performed at KKI Clinical Neurophysiology Laboratory
- age 4 -17 years
- adequate health to tolerate procedure without additional nursing care
- English speaking caregiver, over 18 years of age
- Caregiver must have full guardianship of child participant
- Caregiver must be able to complete written questionnaires and read the educational story to their child
- Caregiver must be able to accompany child participant to the sleep study
Who cannot join
- non-english speaking children
- children in foster care or wards of the state
- child with absence of developmental disability
- child with presence of severe-profound intellectual disability
- child with severe disruptive or aggressive behaviors
- recommended for titration study (CPAP and/or supplemental oxygen)
Show all 12Show fewer
- children requiring behavioral desensitization prior to sleep study.
- Caregivers that are non-English Speaking
- Caregivers that are under 18 years of age
- foster parents or temporary guardians
- cargivers with inability to reach educational story and/or complete questionnaires.
- caregiver is unable to accompany the child to the sleep study
Trial locations and contacts
1 site in 1 country.
United States1 site
Kennedy Krieger Institute
Baltimore, Maryland, 21205
About this study
Official title: Use of an Educational Story to Prepare Children With Developmental Disabilities for Overnight Polysomnography
The investigators hypothesize that use of an educational story with pictures illustrating overnight sleep study procedure (also called polysomnography or PSG)accompanied by simple narrative will be a cost-effective, readily accepted intervention that will contribute to successful completion of sleep studies among children with disabilities. Children who have been referred for a clinical sleep study at Kennedy Krieger Institute (KKI) will be enrolled and randomized to either recieve usual care (discussion of polysomnography with referring clinicians) or educational story intervention. Both groups of participants will be asked to complete questionnaries before and after the sleep study. Set-up for the sleep study will be videotaped so that behavior of the child can be evaluated. The investigators will evaluate whether successful study completion differs between the two groups.
Read the detailed description
This pilot study is a prospective clinical trial comparing parent knowledge of, and child outcomes for clinically indicated PSG which is part of routine care. Comparisons will take place before and after either educational intervention or usual clinical care preparing children for PSG at KKI. Interested families will be recruited through the Kennedy Krieger Institute (KKI) Sleep Disorders Clinic and flyers will be distributed to other KKI subspecialty clinics in which clinically indicated PSG may be ordered. Families for whose children PSG is clinically recommended in KKI Sleep Disorders Clinic will have informed consent obtained from parents and assent from children in clinic, and randomization will occur at that time. Alternately, families for whose children PSG is clinically recommended in that clinic or others may contact the research coordinator for phone screening (telephone script attached) in order to be consented and assented; randomization will then take place once informed consent is received. Families randomized to the educational story intervention group will receive a printed copy of the educational story, as well as instructions on how to use it. Families randomized to the standard clinical care group will receive a set of pictures used in standard clinical care without an accompanying educational story.
The educational story has been developed by the Primary Investigator, who is board certified in Pediatrics and Sleep Medicine, and the Co-Investigator, who has extensive training in child clinical and pediatric psychology. It has also been reviewed by professionals at the KKI Center for Autism and Related Disorders with experience in developing educational materials for children with disabilities. There is a single version of this story that parents will be given to take home and review with their child. It is a short, upbeat narrative about a boy who comes to the investigators pediatric sleep laboratory for his first PSG. It is illustrated with color photographs depicting the entire PSG process (arrival at the laboratory, each step of PSG setup, the final appearance of the child with monitoring applied, the child asleep, and departure the following morning after a successful PSG). The text has a Flesch-Kincaid grade level of 2.5, and Flesch reading ease of 89.4.
Research procedures prior to PSG include completion of the following questionnaires:
- Demographic questionnaire
- Pre-PSG knowledge questionnaire
- Pediatric Symptom Checklist
- Parent Beliefs Scale
These questionnaires will be done 2-3 weeks prior to the night of the PSG.
All families will receive a phone call one week prior to PSG reminding them of their upcoming procedure, and for families in the intervention group, reminding them to review the social story. Parents in the intervention group will be asked to review the story at least 3 times with their child.
Research procedures for parents on arrival the night of the clinically indicated PSG include the following:
- Post-PSG knowledge questionnaire (on arrival at the laboratory)
- Parent Beliefs Scale (on arrival at the laboratory)
Because Dr. Paasch and Dr. Accardo are blinded to the randomization of study subjects, they will be able to score pre-PSG questionnaires and enter data as needed throughout the study.
Research procedures to be completed by sleep technicians the night of the study are the following:
- Adapted Wong-Baker FACES distress scale (based on child distress)
- Audio and video recording of equipment setup. Clinical PSG is accompanied by audio and video recording as part of routine care, but the investigators will extend the video recording to include equipment setup specifically for the purpose of research in order to quantify duration of setup time and number of escape behaviors.
Research procedures for parents prior to discharge from the laboratory will consist of a post-PSG qualitative questionnaire (prior to discharge from the laboratory) regarding their experience in the laboratory. In the case of the intervention group, they will also be asked how the educational story was helpful and whether parents recommended changes to make it more helpful in future.
After completion of the PSG and completion of questionnaires, the study is complete. Therefore the average length of time over which the study takes place, is approximately 3-4 weeks.
Following completion of the clinically indicated PSG performed for clinical care purposes, several steps will occur:
- The PSG will be scored per laboratory protocol by a certified registered PSG technician.
- The Primary Investigator, Dr. Accardo, will review data and generate a clinical interpretation of the PSG detailing whether any sleep concerns or diagnoses were identified during the study.
- Audio and video recording will be reviewed by co-investigator Dr. Valerie Paasch based on the Pediatric Behavior Adjustment Scale (PBAS) to document any child distress and complete task analysis to document the steps which were completed.
- Conditions
- Developmental Disabilities, Sleep Disorders, Polysomnography, Preparation for Medical Procedure, Child
- Being tested
- Educational Story
- Medical subject headings
- Developmental Disabilities, Sleep Wake Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational StoryOther
Also called "The Sleep Study Story"
Educational story with pictures illustrating overnight polysomnography procedure accompanied by simple narrative.
| Study group | Role | What they receive |
|---|---|---|
| Educational Story | Experimental | Participants receiving this intervention will have access to the educational story as they prepare for the overnight sleep study. Receives: Other: Educational Story |
| Typical Preparation | No intervention | Participants will receive traditional materials, directions, what to bring list, only. They will not recieve access to educational story |
What is being measured
The primary outcome is the main question the study is designed to answer.
Task Analysis and Pediatric Behavior Adjustment Scale
Task Analysis: Quantification of number of PSG steps technician was able to complete during setup
Pediatric Behavior Adjustment Scale: Quantification of child escape behaviors during PSG equipment setup based on standardized review of audio and video recording
Measured: PSG Set-UP 2- 3 weeks after enrollment
Secondary outcomes (1)
Parent Completed Questionnaires
- Demographic Questionnaire: Parent and child demographics
- Pre-PSG Knowledge Questionnaire: Baseline parent knowledge about PSG
- Pediatric Symptom Checklist: Cognitive, emotional and behavioral symptoms in child
- Modified PSG Parent Beliefs Scale: Parent perceptions of parent ability to help child cope with procedure as well as child ability to cope with procedure
- Post-PSG Knowledge Questionnaire: Post-intervention parent knowledge about PSG
- Post-PSG Qualitative Questionnaire: Qualitative parent feedback on child and parent PSG experience and on educational intervention if applicable
Measured: 2-3 weeks prior to PSG, and night of Sleep Study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2014 (estimated)
- Study startApr 2014
- Primary completionJun 2016
- Study completionJun 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Developmental DisabilitiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jennifer Accardo
- Sponsor type
- University, hospital or other
- Collaborators
- American Academy of Sleep Medicine
- Responsible party
- Sponsor-investigator, Jennifer Accardo, Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Investigators
- Jennifer Accardo, MD, Principal investigator, Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02132273
- Sponsor's protocol ID
- 100-EP-13
- Status last verified
- Sep 2016
- First submitted
- 5 May 2014
- Last updated
- 27 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of an Educational Story to Prepare Children With Developmental Disabilities for Overnight Polysomnography
- ClinicalTrials.gov ID
- NCT02132273
- Acronym / sponsor ID
- 100-EP-13
- Conditions
- Developmental Disabilities, Sleep Disorders, Polysomnography, Preparation for Medical Procedure, Child
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Jennifer AccardoUniversity, hospital or other
- Collaborators
- American Academy of Sleep Medicine
- Study start
- Apr 2014
- Primary completion
- Jun 2016 (actual)
- Study completion
- Jun 2016 (actual)
- First posted
- 7 May 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators hypothesize that use of an educational story with pictures illustrating overnight sleep study procedure (also called polysomnography or PSG)accompanied by simple narrative will be a cost-effective, readily accepted intervention that will contribute to successful completion of sleep studies among children with disabilities. Children who have been referred for a clinical sleep study at Kennedy Krieger Institute (KKI) will be enrolled and randomized to either recieve usual care (discussion of polysomnography with referring clinicians) or educational story intervention. Both groups of participants will be asked to complete questionnaries before and after the sleep study. Set-up for the sleep study will be videotaped so that behavior of the child can be evaluated. The investigators will evaluate whether successful study completion differs between the two groups.
Detailed description
This pilot study is a prospective clinical trial comparing parent knowledge of, and child outcomes for clinically indicated PSG which is part of routine care. Comparisons will take place before and after either educational intervention or usual clinical care preparing children for PSG at KKI. Interested families will be recruited through the Kennedy Krieger Institute (KKI) Sleep Disorders Clinic and flyers will be distributed to other KKI subspecialty clinics in which clinically indicated PSG may be ordered. Families for whose children PSG is clinically recommended in KKI Sleep Disorders Clinic will have informed consent obtained from parents and assent from children in clinic, and randomization will occur at that time. Alternately, families for whose children PSG is clinically recommended in that clinic or others may contact the research coordinator for phone screening (telephone script attached) in order to be consented and assented; randomization will then take place once informed consent is received. Families randomized to the educational story intervention group will receive a printed copy of the educational story, as well as instructions on how to use it. Families randomized to the standard clinical care group will receive a set of pictures used in standard clinical care without an accompanying educational story.
The educational story has been developed by the Primary Investigator, who is board certified in Pediatrics and Sleep Medicine, and the Co-Investigator, who has extensive training in child clinical and pediatric psychology. It has also been reviewed by professionals at the KKI Center for Autism and Related Disorders with experience in developing educational materials for children with disabilities. There is a single version of this story that parents will be given to take home and review with their child. It is a short, upbeat narrative about a boy who comes to the investigators pediatric sleep laboratory for his first PSG. It is illustrated with color photographs depicting the entire PSG process (arrival at the laboratory, each step of PSG setup, the final appearance of the child with monitoring applied, the child asleep, and departure the following morning after a successful PSG). The text has a Flesch-Kincaid grade level of 2.5, and Flesch reading ease of 89.4.
Research procedures prior to PSG include completion of the following questionnaires:
- Demographic questionnaire
- Pre-PSG knowledge questionnaire
- Pediatric Symptom Checklist
- Parent Beliefs Scale
These questionnaires will be done 2-3 weeks prior to the night of the PSG.
All families will receive a phone call one week prior to PSG reminding them of their upcoming procedure, and for families in the intervention group, reminding them to review the social story. Parents in the intervention group will be asked to review the story at least 3 times with their child.
Research procedures for parents on arrival the night of the clinically indicated PSG include the following:
- Post-PSG knowledge questionnaire (on arrival at the laboratory)
- Parent Beliefs Scale (on arrival at the laboratory)
Because Dr. Paasch and Dr. Accardo are blinded to the randomization of study subjects, they will be able to score pre-PSG questionnaires and enter data as needed throughout the study.
Research procedures to be completed by sleep technicians the night of the study are the following:
- Adapted Wong-Baker FACES distress scale (based on child distress)
- Audio and video recording of equipment setup. Clinical PSG is accompanied by audio and video recording as part of routine care, but the investigators will extend the video recording to include equipment setup specifically for the purpose of research in order to quantify duration of setup time and number of escape behaviors.
Research procedures for parents prior to discharge from the laboratory will consist of a post-PSG qualitative questionnaire (prior to discharge from the laboratory) regarding their experience in the laboratory. In the case of the intervention group, they will also be asked how the educational story was helpful and whether parents recommended changes to make it more helpful in future.
After completion of the PSG and completion of questionnaires, the study is complete. Therefore the average length of time over which the study takes place, is approximately 3-4 weeks.
Following completion of the clinically indicated PSG performed for clinical care purposes, several steps will occur:
- The PSG will be scored per laboratory protocol by a certified registered PSG technician.
- The Primary Investigator, Dr. Accardo, will review data and generate a clinical interpretation of the PSG detailing whether any sleep concerns or diagnoses were identified during the study.
- Audio and video recording will be reviewed by co-investigator Dr. Valerie Paasch based on the Pediatric Behavior Adjustment Scale (PBAS) to document any child distress and complete task analysis to document the steps which were completed.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Educational Story | Experimental | Other: Educational StoryParticipants receiving this intervention will have access to the educational story as they prepare for the overnight sleep study. |
| Typical Preparation | No intervention | –Participants will receive traditional materials, directions, what to bring list, only. They will not recieve access to educational story |
Who may qualify
- Ages
- 4 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- Clinical recommendation for polysomnography to be performed at KKI Clinical Neurophysiology Laboratory
- age 4 -17 years
- adequate health to tolerate procedure without additional nursing care
- English speaking caregiver, over 18 years of age
- Caregiver must have full guardianship of child participant
Key exclusion criteria (12 listed)
- non-english speaking children
- children in foster care or wards of the state
- child with absence of developmental disability
- child with presence of severe-profound intellectual disability
- child with severe disruptive or aggressive behaviors
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Educational StoryAlso: "The Sleep Study Story"Educational story with pictures illustrating overnight polysomnography procedure accompanied by simple narrative. | Other | Educational Story |
Primary outcome
Task Analysis and Pediatric Behavior Adjustment Scale
Time frame: PSG Set-UP 2- 3 weeks after enrollment
Task Analysis: Quantification of number of PSG steps technician was able to complete during setup Pediatric Behavior Adjustment Scale: Quantification of child escape behaviors during PSG equipment setup based on standardized review of audio and video recording
1 secondary outcome
Parent Completed Questionnaires
Time frame: 2-3 weeks prior to PSG, and night of Sleep Study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Sep 2016.
- Individual participant dataSharing planned: No
Related trials for Developmental Disabilities
RecruitingPhase 1
Cannabidiol (CBD) in Adults With ASD
Autism Spectrum Disorder
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Sensory-integration Therapy Verses Augumented Reality-based Training in ASD
Autism Spectrum Disorder
Recruiting
Cumulative and Booster Effects of Multisession Prefrontal tDCS in ASD Adolescents
Transcranial Direct Current Stimulation, Autistic Spectrum Disorder
Not yet recruiting
"Family Resilience And Mind-body Enhancement" (FRAME): A Randomised Controlled Trial
Autism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jennifer Accardo, MD principal investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Educational Story in people with Developmental Disabilities and Sleep Disorders, run by Jennifer Accardo at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Task Analysis and Pediatric Behavior Adjustment Scale (time frame: PSG Set-UP 2- 3 weeks after enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2016.